CNSX:CLPharmaceuticals
Cresco Labs (CNSX:CL) Stock Turns Profitable But Margin Durability Remains Unclear
Cresco Labs went into this earnings print as a discounted cannabis stock, trading at CA$1.05 and sitting well below some valuation estimates despite a weak 90 day return. The story so far has been about cheap revenue and lingering losses. The headline today is different. Q2 flipped to a profit on a basic earnings per share of US$0.045 and revenue of US$173.3m, backed by US$40m of adjusted earnings before interest, tax, depreciation and amortization. The gap between the low share price and...